Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters

• Kairat Tabynov,
• Maxim Solomadin,
• Nurkeldi Turebekov,
• Meruert Babayeva,
• Gleb Fomin,
• Ganesh Yadagiri,
• Sankar Renu,
• Toktassyn Yerubayev,
• Nikolai Petrovsky,
• Gourapura J. Renukaradhya,
• Kaissar Tabynov

Affiliations

Kairat Tabynov

International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU)

Maxim Solomadin

International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU)

Nurkeldi Turebekov

Central Reference Laboratory, M. Aikimbayev National Scientific Center for Especially Dangerous Infections

Meruert Babayeva

International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU)

Gleb Fomin

International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU)

Ganesh Yadagiri

Center for Food Animal Health, College of Food Agricultural and Environmental Sciences, The Ohio State University (OSU)

Sankar Renu

Center for Food Animal Health, College of Food Agricultural and Environmental Sciences, The Ohio State University (OSU)

Toktassyn Yerubayev

Central Reference Laboratory, M. Aikimbayev National Scientific Center for Especially Dangerous Infections

Nikolai Petrovsky

Vaxine Pty Ltd

Gourapura J. Renukaradhya

Center for Food Animal Health, College of Food Agricultural and Environmental Sciences, The Ohio State University (OSU)

Kaissar Tabynov

International Center for Vaccinology, Kazakh National Agrarian Research University (KazNARU)